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Leukemia inhibitory factor (LIF) stimulates the growth of primordial germ cells (PGCs) in mouse embryo. However, as
neither mice lacking LIF nor mice lacking the LIF receptor show defects in PGC growth, an alternate cytokine for PGC
growth has been postulated. We investigated the role of mouse oncostatin M (mOSM), which is structurally and functionally
related to LIF, in germ cell development. While LIF enhanced the survival of migratory as well as postmigratory PGCs,
mOSM acted only on the postmigratory PGCs. Consistent with its biological activity, mOSM was found to be expressed in
developing gonads. In the male, Sertoli cells in neonatal testis express mOSM; however, its expression is downregulated in
adult testes. Moreover, mOSM enhanced the proliferation of Sertoli cells derived from neonatal testes in vitro more than
human OSM or LIF. In contrast, postnatal ovaries do not express mOSM. These results indicate that mOSM is a stage- and
sex-specific autocrine growth factor for Sertoli cells. © 1998 Academic Press
INTRODUCTION
Long-term culture of primordial germ cells (PGCs)2 in
vitro to manipulate the germ line has been a major interest
for developmental biologists. As a first step, an in vitro
culture method for PGCs has been established in mice
using stem cell factor (SCF), basic fibroblast growth factor
(bFGF), and leukemia inhibitory factor (LIF) in the presence
of a feeder cell layer (Dolci et al., 1991; Matsui et al., 1992;
Resnick et al., 1992). In mouse embryos, PGCs at the base
of the allantois of 8.5 days postcoitum (dpc) start to prolif-
erate, while migrating to the developing gonad (growth of
migratory PGCs) through the hindgut mesentery during the
following 3–4 days (see a review by Donovan, 1994). Based
on the in vitro studies and genetic mutants, this process is
known to be regulated by various cytokines, including SCF,
bFGF, LIF, and transforming growth factor b (Dolci et al.,
1991; Godin and Wylie, 1991; Matsui et al., 1992; Resnick
et al., 1992). In particular, members of the interleukin
(IL)-6/LIF cytokine family which utilize gp130 as a common
signal transducer play a critical role in the proliferation and
survival of PGCs, since LIF, human oncostatin M (hOSM),
ciliary neurotrophic factor (CNTF), or the combination of
IL-6 and soluble IL-6 receptor (sIL-6R) stimulates PGC
growth in vitro (Cheng et al., 1994; Koshimizu et al., 1996).
Moreover, the PGC number in gonads of gp130-deficient
mice is significantly reduced (T. Taga, personal communi-
cation). Although LIF, hOSM, and CNTF are known to
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utilize the LIF receptor b subunit (LIFRb) as a part of the
functional receptors (Davis et al., 1993; Gearing et al.,
1992), knockout mice lacking LIF or the LIFRb produce an
equivalent number of PGCs (Stewart et al., 1992; Ware et
al., 1995). In addition, the fact that null-mutant mice for
CNTF and IL-6 retain a normal number of PGCs (Kopf et
al., 1994; Masu et al., 1993) prompted us to find a new
member of the IL-6/LIF cytokine family which is critically
involved in the PGC development.
OSM was first cloned in human as a growth-inhibitory
cytokine for a melanoma cell line (Zarling et al., 1986).
Later, hOSM was identified as an autocrine growth factor
for Kaposi’s sarcoma (Miles et al., 1992). Although LIF and
OSM are most closely related functionally, structurally,
and genetically (Bruce et al., 1992; Jeffery et al., 1993; Rose
and Bruce, 1991; Rose et al., 1994), physiological roles of
OSM have not been elucidated because rodent counterparts
had not been isolated until recently, when we cloned mouse
OSM (mOSM) cDNA as a cytokine-inducible early response
gene in hematopoietic cells (Yoshimura et al., 1996).
mOSM expression is induced by cytokines such as IL-3 and
erythropoietin through the activation of Janus kinases and
signal transducer and activator of transcription-5 (STAT5)
(Mui et al., 1996; Yoshimura et al., 1996). In adult mice,
mOSM is predominantly expressed in bone marrow, thy-
mus, and spleen (Yoshimura et al., 1996). On the other
hand, in mouse embryos at 11.5–13.5 dpc, its expression
was detected in gonads in both males and females (Muk-
ouyama et al., 1998).
There are two functional receptor complexes for hOSM:
one is composed of gp130 and LIFRb (Gearing et al., 1992;
Thoma et al., 1994), the other consists of gp130 and the
OSM receptor b chain (OSMRb) (Mosley et al., 1996). Our
recent studies on the functional receptor for mOSM re-
vealed that in contrast to hOSM, mOSM does not activate
the LIF receptor complex. Instead, mOSM utilizes only the
OSM-specific receptor complex, which is presumably com-
posed of gp130 and OSMRb (Ichihara et al., 1997; Richards
et al., 1997). In some cells such as embryonic stem cells,
functional OSMR is absent due to the lack of OSMRb
(Ichihara et al., 1997; M. Tanaka, T.H., A.M., manuscript
submitted). Thus, the functions of OSM and LIF are segre-
gated in mice. Moreover, hOSM does not cross-react with
the mouse OSM receptor, but does function through the LIF
receptor (Ichihara et al., 1997; Richards et al., 1997). It is
therefore important to reevaluate the biological activities of
OSM by using mOSM in mice.
Once mouse PGCs migrate into gonads at 10–11 dpc,
they are further expanded (postmigratory PGC growth) and
start to differentiate in a sex-specific fashion: i.e., male
germ cells enter mitotic arrest until birth and then resume
proliferation, while female germ cells are arrested in
prophase of meiosis (Donovan, 1994). In the male, somatic
cells in gonads such as Sertoli cells and mesenchymal cells
proliferate and differentiate cooperatively along with germ
cells to form seminiferous tubules in the testis by 9–10 days
postpartum (dpp), when spermatogenic cells enter meiosis.
By 35 dpp, seminiferous tubules in mice become function-
ally mature to produce spermatozoa (Bellve et al., 1977;
Skinner et al., 1985; see a review by Orth, 1993). Recent
studies have suggested that LIF, hOSM, or CNTF promotes
the growth of Sertoli cells and gonocytes in a coculture
system of rat testes (de Miguel et al., 1996, 1997). In this
study, we confirm the expression of mOSM in gonads and
neonatal testes and demonstrate unique biological activi-
ties of mOSM during the course of PGC and testis develop-
ment in mice.
MATERIALS AND METHODS
Mice. For PGC assays, mouse embryos from B6C3F1 breeding
pairs (NCI–FCRDC) were used. In situ hybridization of frozen
sections of testes and ovaries and primary culture of neonatal testes
were carried out using C57BL/6 (Nihon SLC, Hamamatsu, Japan).
PGC assays. PGCs were cultured as previously described (Don-
ovan et al., 1986). In brief, caudal fragments from embryos at 8.5
dpc or gonadal regions from embryos at 11.5 dpc were trypsinized
into a single-cell suspension and inoculated in 96-multiwell plates
containing 200 ml of Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 15% fetal bovine serum (FBS) and sodium
pyruvate in the presence of various cytokines. The plates were
precoated with 0.1% gelatin and SCF (100 ng/ml). Concentrations
of cytokines used were 10 ng/ml for mOSM (Ichihara et al., 1997),
mLIF, and hOSM (R&D Systems), 100 ng/ml for SCF (R&D
Systems), and 1 ng/ml for human bFGF (Gibco), respectively. After
2 days of culture, the number of alkaline phosphatase (AP)-positive
cells was counted.
In situ hybridization. Male embryos at 13.5 dpc and testes and
ovaries from mice at 0.5, 8, and 21 dpp were fixed directly at 4°C in
0.1 M phosphate buffer (pH 7.45) containing 4% paraformaldehyde
overnight. They were then soaked in a series of sucrose solutions
(10–30%) in 50 mM phosphate buffer overnight and embedded in
the OCT compound (Miles, Inc., Elkhart, IN). Ten-micrometer-
thick sections were cut by cryostat and mounted on microscope
slides coated with poly-L-lysine. Sections were dried immediately
after mounting and kept at 225°C until use. Paraffin-embedded
sections (6 mm thick) of testes were prepared as previously de-
scribed (de Miguel et al., 1997). Digoxigenin-labeled antisense and
sense riboprobes were prepared using the mOSM cDNA fragment
(nucleotide 211–507) in the pCRII vector (Invitrogen) and an RNA
transcription kit (Stratagene) according to the manufacturer’s in-
structions. As described previously (Imakawa et al., 1995), hybrid-
ization was performed in a humidified oven at 42°C for 18 h, and
bound probes were visualized using AP-conjugated anti-digoxigenin
antibody and nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl
phosphate as substrates.
Immunohistochemical analysis. For the characterization of
primary testicular cells, rat anti-Wilms tumor (WT)-1 monoclonal
antibody (Murata et al., 1997) (kindly provided by Dr. T. Akiyama,
Tokyo University) was used to stain fixed cells, and bound anti-
body was visualized with 3,39-diaminobenzidine (DAB; Sigma).
Preparation of testicular cells and culture conditions. Testes
from mice at 0.5 dpp were decapsulated and subjected to enzymatic
digestion with 0.1% hyaluronidase (Sigma), 0.1% collagenase
(Wako, Osaka), and deoxyribonuclease I (0.1 mg/ml) (Boehringer
Mannheim) at 37°C for 40 min. They were agitated and further
incubated in 0.1% trypsin–0.5 mM EDTA at 37°C for 5 min. Cells
were well suspended and subjected to culture in DMEM supple-
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mented with 15% FBS or serum-free medium for Sertoli cells (de
Miguel et al., 1996), which is composed of DMEM/Ham’s F-12 (1/1
v/v) supplemented with vitamin A, transferrin, insulin, and bovine
serum albumin. To examine the cytokine response of testicular
cells, mOSM, hOSM, or mLIF was added to the serum-containing
or the serum-free medium at the concentration of 10 ng/ml. After
3–6 days in culture, viable cells, which exclude trypan blue, were
counted.
Radioimmunoassay for inhibin. Second passage of the neona-
tal testicular cells (3 3 106 cells) in the culture containing FBS and
mOSM, adherent cells (3 3 106 cells) derived from the gonadal
region of mouse embryos at 11.5 dpc (Mukouyama et al., 1998), and
granulosa cells (2 3 105 cells) from adult ovaries were cultured for
3 days. Ovarian granulosa cells were prepared and cultured as
described before (Asakai et al., 1995). The amount of inhibin-a
released in the medium was determined by radioimmunoassay
using a rabbit antiserum against bovine inhibin as previously
described (Hamada et al., 1989). The intra- and interassay coeffi-
cients of variation were 4.6 and 4.9%. respectively.
RESULTS
Effect of mOSM on PGC Growth
We produced recombinant mOSM and tested whether
mOSM can substitute in the role of LIF in the PGC culture.
As has been reported (Cheng et al., 1994; Resnick et al.,
1992), LIF in the presence of SCF and bFGF enhanced the
survival of migratory PGCs derived from embryos at 8.5 dpc
(Fig. 1A). Likewise, hOSM enhanced the survival of PGCs
in the presence of SCF and bFGF. In contrast, mOSM failed
to promote such survival activity in the migratory PGCs
(Fig. 1A). This assay was performed in the absence of feeder
cells such as irradiated STO cells, because mOSM was
cytotoxic to the feeder cells (data not shown).
Next, we examined the effect of mOSM on postmigratory
PGCs from gonads at 11.5 dpc. As shown in Fig. 1B, mOSM
enhanced the survival of PGCs in the presence of SCF and
bFGF in a dose-dependent manner. In addition, LIF and
mOSM additively enhanced the survival of PGCs (Fig. 1B).
A similar result was obtained in an independent experiment
(data not shown). When the primary culture of the gonadal
region at 11.5 dpc was continued up to 7 days, growth of
endothelial cells and hematopoietic cells was stimulated by
mOSM specifically (Mukouyama et al., 1998). Therefore it
is possible that mOSM indirectly enhanced PGC survival
by stimulating such somatic cells or fibroblastic cells in the
culture. These results indicate that LIF as well as hOSM
stimulates PGCs, but mOSM acts on PGCs in a distinct
manner.
Expression of mOSM in Testes and Ovaries
We previously detected mOSM mRNA in the gonadal
region at 11.5–13.5 dpc in both male and female (Muk-
FIG. 2. Detection of mOSM mRNA in testis and ovary by in situ hybridization. Paraffin-embedded sections from mouse testis at 0.5 dpp
(A and B), frozen sections from mouse testes at 8 (C and D) and 21 dpp (E and F), and frozen sections from mouse ovary at 0.5 dpp (G and
H) were hybridized with a digoxigenin-labeled antisense mOSM cRNA probe (A, C, E, and G) or a digoxigenin-labeled sense control probe
(B, D, F, and H). Blue stainings in Sertoli cells (large arrowheads in A) and some of the interstitial cells (small arrowheads in A) respresent
mOSM mRNA signals. Original magnification: 503 (A, B), 333 (C, D), 253 (E, F), and 403 (G, H).
FIG. 1. Cytokine response of primordial germ cells (PGCs). Caudal fragments at 8.5 dpc (0.5 embryo/well) (A) or gonadal regions at 11.5
dpc (0.4 embryo/well) (B) were trypsinized and inoculated into multiwell plates containing various cytokines as indicated. Unless indicated,
concentrations of LIF, hOSM, and mOSM were at 10 ng/ml. After 2 days in culture, alkaline phosphatase-positive cells were counted as
PGCs in each well. Each value represents an average of PGC number in triplicate wells with standard deviation (each bar).
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ouyama et al., 1998). The other study in rat revealed the
expression of an OSM-like protein in testes from 19 dpc to
15 dpp (de Miguel et al., 1997). Therefore, we considered
that mOSM may be involved in the development of repro-
ductive organs in mice. We first examined the expression of
mOSM in testes and ovaries by in situ hybridization using
an antisense cRNA probe. mOSM mRNA (stained in blue
color) was detected in testis sections from mice at 0.5 dpp
(Fig. 2A), but not in testes at 8 (Fig. 2C) nor at 21 dpp (Fig.
2E). In the neonatal testis section, the mOSM expression
was localized in the Sertoli cells (large arrowheads in Fig.
2A) and some of the interstitial cells (small arrowheads in
Fig. 2A) but not in gonocytes (round, larger cells inside the
seminiferous tubules in Fig. 2A). A sense cRNA probe to
mOSM did not hybridize to any cells in the testes sections
(Figs. 2B, 2D, and 2F).
In a male embryonic section at 13.5 dpc, mOSM was
identified in gonad, metanephros, cartilage, dorsal root
ganglion, and spinal cord (Fig. 3A). By close examination of
the male gonad, mOSM expression was detected in cells
inside the immature testis cords. (Fig. 3C). On the other
hand, when ovary sections from mice at 0.5, 8, and 21 dpp
were analyzed by in situ hybridization using the same
cRNA probes to mOSM, no significant expression of
mOSM was observed in any stage of ovaries (Figs. 2G and
2H, data not shown). Taken together, these data suggested
that the mOSM transcript is expressed mainly in Sertoli
cells in testes from fetal to neonatal stages, but is absent in
testes after 8 dpp. Such postnatal expression of mOSM
mRNA does not occur in ovaries. We observed similar
expression patterns of mOSM protein in testis and ovary
sections using an anti-mOSM polyclonal antibody (unpub-
lished data).
Proliferative Response of Sertoli Cells to mOSM
Since the expression pattern of mOSM in testes correlates
with the proliferative stage of Sertoli cells, we tested the
possibility that mOSM directly stimulates the growth of
Sertoli cells in neonatal mouse testes. When testicular cells
from testes at 0.5 dpp were cultured in the serum-
containing medium in the absence of cytokine for 6 days,
only few cells survived and most of the cells became
senescent (Fig. 4A). In contrast, the addition of mOSM on
day 3 in this culture strongly induced proliferation of
testicular cells during the following 3 days (Fig. 4B). In a
long-term culture of the testicular cells in the presence of
mOSM, Sertoli-like cells became aggregated to form a
cord-like structure (data not shown), indicative of differen-
tiated Sertoli cells (see a review by Orth, 1993).
To examine if mOSM-responsive cells include Sertoli
cells, we examined the WT-1 expression as a marker of
Sertoli cells by immunohistochemical staining. As shown
in Fig. 4C, a major population of the OSM-responsive cells
derived from the neonatal testes exhibited positive signals
(brown stain) in their nuclei. Such signals were not seen in
the absence of the primary antibody (Fig. 4D), indicating
that many of the neonatal testicular cells cultured in the
presence of mOSM express WT-1. As another functional
assay for Sertoli cells, we measured inhibin production
from the primary culture of neonatal testicular cells in the
FIG. 3. Detection of mOSM mRNA in mouse male gonad by in situ
hybridization. Frozen sections of the urogenital region (transverse
section) of mouse fetus at 13.5 dpc were hybridized with a
digoxigenin-labeled antisense mOSM cRNA probe (A and C) or a
digoxigenin-labeled sense control probe (B). Positive blue stainings
were observed in developing testis cord (arrowheads), metanephric
region (small arrow), cartilage primordium (asterisks), dorsal root
ganglion (stars), and spinal cord (large arrow). Original magnification
was 403 (A, B) and the gonad region in A was further enlarged (C).
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presence of mOSM. Inhibin production has been shown to
specifically occur in Sertoli cells in testes (Matzuk et al.,
1992). Radioimmunoassays using an anti-inhibin-a anti-
body showed that such OSM-responsive testicular cells
produced a significant amount of inhibin (Table 1). As the
total amount of inhibin produced from the testicular cells
was smaller than that from cultured adult granulosa cells,
but larger than that from indifferent gonadal cells (Table 1),
the cultured neonatal testicular cells seem to contain both
undifferentiated and mature Sertoli cells.
We next employed the serum-free culture method which
has been optimized for the growth of Sertoli cells in rat (de
Miguel et al., 1996). When cells from neonatal testes were
cultured in the serum-free medium in the absence or
presence of mOSM, hOSM, or mLIF, the highest degree of
cell proliferation occurred in the mOSM-containing culture
(Figs. 5 and 6). The cells grown in response to mOSM appear
to be less adherent and aggregate with one another to form
focus-like structures (Fig. 5B). Proliferative responses of the
neonatal testicular cells to mOSM, hOSM, and mLIF in two
different culture conditions were compared in Fig. 6. The
same experiment was done more than twice and similar
results were obtained (data not shown). In all cases, mOSM
elicited a maximal growth signal to the neonatal testicular
cells. They were still capable of responding to mOSM even
after culturing in the absence of cytokine for 3 days (Fig.
6B). It is of notice that the cells cultured in the absence of
cytokine were responsive to hOSM or mLIF only in the
FIG. 4. Growth stimulation by mOSM of neonatal testicular cells. Enzymatically separated cells from testes at 0.5 dpp were cultured for
3 days in the absence of cytokine and thereafter stimulated with 10 ng/ml mOSM for 3 days in the serum-containing medium.
Phase-contrast microscopic appearances of cells cultured in the absence (A) or presence (B) of mOSM are shown. The neonatal testicular
cells grown in the presence of mOSM were stained with (C) or without (D) anti-WT-1 monoclonal antibody followed by visualization with
DAB. Original magnification: 1003 (A, B), 2003 (C, D).
TABLE 1
Production of Inhibin-a by Cultured Neonatal Testicular Cells
Cell type Concentration (ng/ml)a
Testicular cells at 0.5 dpp 8.15 6 2.24
Gonadal cells at 11.5 dpc 0.89 6 0.06
Adult granulosa cells 15.7 6 3.25
a Each value shows a mean 6 standard deviation of triplicate
samples.
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serum-free condition (Fig. 6B). This is probably due to the
predominant expansion of Sertoli cells in the serum-free
medium.
Taking together all data described above and the fact that
Sertoli cells produce mOSM (Fig. 2), we conclude that
mOSM is involved in testicular development as an auto-
crine growth factor for Sertoli cells.
DISCUSSION
In this study, we demonstrated two major biological
activities of mOSM in germ cell and testicular develop-
ment. First, mOSM supports the survival of postmigratory
PGCs, but not migratory PGCs in vitro. Second, the growth
of Sertoli cells in neonatal testis is stimulated by mOSM. In
both cases, the effects of LIF and hOSM are quite distinct
from that of mOSM. The difference between mOSM and
hOSM/LIF is explained well molecularly by our recent
findings as follows (Ichihara et al., 1997; Richards et al.,
1997; M. Tanaka, T.H., A.M., manuscript submitted). First,
the LIF receptor complex, which consists of gp130 and
LIFRb, binds to LIF as well as hOSM with high affinity,
while mOSM binds it with only low affinity and does not
activate the LIF receptor. Second, the mOSM-specific recep-
tor complex, which consists of gp130 and OSMRb, is
species-specific and hOSM does not activate the mOSM
receptor. As both LIF and OSM receptors consist of a
ligand-specific subunit (LIFRb or OSMRb) and gp130 (Mos-
ley et al., 1996 M. Tanaka, T.H., A.M., manuscript submit-
ted), and the activation of gp130 by the addition of IL-6 and
sIL-6R induces signals (Ichihara et al., 1997; Mukouyama et
al., 1998), different cellular responses between LIF and OSM
are most likely due to a distinct expression spectrum of
their receptor b subunits. It is speculated that Sertoli cells
in the neonatal testis express OSMRb, while a smaller
population of Sertoli cells express LIFRb. There are several
mouse cell lines, including NIH3T3 and newly established
gonad-derived OSM-dependent cell lines (T.H., Y.M., A.M.,
unpublished), which respond only to OSM and not to LIF. It
is an interesting contrast that expression of LIFRb and
OSMRb in human organs and various cell lines widely
overlaps (Mosley et al., 1996).
Our initial goal was to identify a critical member of the
IL-6/LIF cytokine family for PGC growth. The combination
of SCF, bFGF, LIF and mOSM appears to be the most
FIG. 5. Morphology of neonatal Sertoli cells stimulated with mOSM, hOSM, and mLIF. Enzymatically separated cells from testes at 0.5
dpp were cultured for 3 days in the absence (A) or presence of mOSM (B), hOSM (C), or mLIF(D) in the serum-free medium which is suitable
for the Sertoli cell growth. Phase-contrast microscopic appearances of cells are shown. Original magnification: 1003.
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effective in the culture of postmigratory PGCs. As the
primary culture of gonads at 11.5 dpc includes not only
PGCs but also mesenchyme-derived various types of so-
matic cells, the effect of mOSM on postmigratory PGCs can
be either direct or indirect through the activation of so-
matic cells. As the purified PGCs have been shown to
express LIFRb (Cheng et al., 1994), examining the expres-
sion of OSMRb in both migratory and postmigratory PGCs
will provide a clear picture. How long can PGCs be main-
tained in this culture condition with mOSM? Unexpect-
edly, AP-positive PGCs disappeared within 4 days and
instead endothelial cells and hematopoietic progenitors
dominated the culture after 10 days (Mukouyama et al.,
1998). Although it is possible that a critical PGC growth
factor is still yet to be identified, the self-renewal potential
of PGCs might be lost by shutting down the expression
and/or the activation of the receptor and signaling pathways
during in vitro culture. This may also reflect one of the
PGC differentiation programs in vivo. Embryonic stem
cells and embryonic germ cells have overcome this problem
by acquiring the continuous responsiveness to LIF. It is
therefore interesting to investigate the fate of PGCs if
LIFRb is constitutively expressed in PGCs by a transgenic
technique.
The finding of the mOSM expression in neonatal testis
and growth stimulation of Sertoli cells in vitro clearly
demonstrates the unique role of OSM in the testicular
development. The mOSM gene has to be transcriptionally
or posttranscriptionally regulated in order to be turned on
in the developmental stages from gonad to early postnatal
testis. In female, the mOSM gene is active in female gonad
at 13.5 dpc (Mukouyama et al., 1998), but becomes silent in
postnatal ovaries. We have previously demonstrated that
transcription of OSM is positively regulated by STAT5 after
cytokine stimulation (Mui et al., 1996; Yoshimura et al.,
1996). However, STAT5 may not be solely responsible for
the OSM expression as adult testis produces STAT5 but yet
fails to express the OSM mRNA (Mui et al., 1996). A
testis-specific transcription factor(s) may modulate the
STAT5 activity in testis. It is of great interest to understand
the mechanism of restricting the mOSM expression only in
male in a stage-specific manner, when Sertoli cells prolif-
erate to constitute the functional seminiferous tubules in
testis.
In the previous study, LIF and hOSM were shown to
support proliferation of Sertoli cells and gonocytes in the
coculture system of rat juvenile testis (de Miguel et al.,
1996, 1997). Furthermore, OSM-like protein was identified
in rat testes and its expression decreased age dependently.
The data presented in this work are totally consistent with
these findings in rat except that mOSM is a more potent
growth factor than hOSM for Sertoli cells. This may be due
to a species-specific action of OSM on their receptors. The
growth-stimulatory effect of hOSM on rat Sertoli cells was
shown to be more potent than that of LIF in the previous
report (de Miguel et al., 1997). Considering the fact that
hOSM does not activate the mouse OSM receptor, hOSM
could cross-react with a yet unidentified rat OSM receptor.
Nonetheless, two lines of evidence in both rat and mouse
proved that OSM is one of the critical growth factors for
Sertoli cells in testis development.
OSM is known to induce tissue inhibitor of metallo-
proteinase-1 (TIMP-1) more than any other IL-6/LIF family
cytokine (Richards et al., 1993, 1997). It was recently
reported that Sertoli cells produce a steroidogenesis-
inducing factor consisting of TIMP-1 and the proenzyme
form of cathepsin L for Leydig cells in response to follicle-
stimulating hormone (FSH) (Boujrad et al., 1995). Interest-
ingly, neonatal rat Sertoli cells produce a higher level of
OSM when treated with FSH in vitro (de Miguel and van
FIG. 6. Proliferative responses of the neonatal testicular cells to
mOSM, hOSM, and mLIF. (A) Dissociated cells (1.1 3 105/well) from
testes at 0.5 dpp were cultured in the absence or presence of mOSM,
hOSM, or mLIF in the serum-containing medium (solid bars) or the
serum-free medium (hatched bars) in six-well plates. After 6 days in
culture, total viable cell number was counted. (B) The neonatal
testicular cells were cultured in the absence of cytokine for 3 days and
a second passage of cells (1.4 3 105/well) was then cultured in the
serum-containing (solid bars) or the serum-free (hatched bars) medium
with or without indicated cytokines in six-well plates. After 4.5 days
in culture, total viable cell number was counted. Each value repre-
sents an average of cell number in triplicate wells with standard
deviation (each horizontal bar).
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Dissel-Emiliani, unpublished obsevations). It is thus tempt-
ing to speculate that OSM is not only involved in the
proliferation of Sertoli cells but also plays a functional role
in the hormonal control of testis. Analysis of mice lacking
the mOSM gene, which is currently being generated, will
provide the definitive answer as to the role of OSM in the
PGC development and spermatogenesis.
In conclusion, our studies using a rodent model uncov-
ered the physiological role of OSM in the development of
germ cells and testis. The newly established culture
method of testiclular cells using mOSM would help future
analyses of complex processes of germ cell and testis
development.
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